Mamocan, Roger L.
HRN: 23-36-80 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/23/2023
07/29/2023
IV
500mg
Q8hrs
AGE With Severe DHN
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes